We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Columbia Sportswear
COLM
$3.29B
| $390K | ﹤0.01% |
+4,801
| New | +$381K |
|
2002
Lindsay Corp
LNN
$1.18B
| $387K | ﹤0.01% |
+3,287
| New | +$409K |
|
2003
Ultralife
ULBI
$92.3M
| $386K | ﹤0.01% |
43,847
-769
| -2% | -$6.26K |
|
|
CALB
2004
DELISTED
California BanCorp Common Stock
CALB
| $386K | ﹤0.01% |
+17,546
| New | +$412K |
|
2005
Cerus
CERS
$591M
| $383K | ﹤0.01% |
+202,578
| New | +$413K |
|
2006
Lifezone Metals
LZM
$296M
| $381K | ﹤0.01% |
+49,691
| New | +$325K |
|
2007
PUT
iShares MSCI South Korea ETF
EWY
$21.4B
| $380K | ﹤0.01% |
+5,800
| New | +$368K |
|
2008
Mirum Pharmaceuticals
MIRM
$6.89B
| $379K | ﹤0.01% |
+15,100
| New | +$415K |
|
2009
UWM Holdings
UWMC
$638M
| $378K | ﹤0.01% |
+52,050
| New | +$351K |
|
2010
Brinker International
EAT
$8.41B
| $377K | ﹤0.01% |
7,580
-722,384
| -99% | -$32M |
|
2011
Everspin Technologies
MRAM
$328M
| $375K | ﹤0.01% |
+47,323
| New | +$403K |
|
2012
Costamare
CMRE
$1.86B
| $374K | ﹤0.01% |
+32,939
| New | +$365K |
|
2013
TD Synnex
SNX
$19.5B
| $373K | ﹤0.01% |
+3,300
| New | +$343K |
|
2014
iShares MSCI Netherlands ETF
EWN
$558M
| $372K | ﹤0.01% |
+7,522
| New | +$350K |
|
2015
National Beverage
FIZZ
$3.04B
| $370K | ﹤0.01% |
+7,800
| New | +$382K |
|
|
JMIA
2016
Jumia Technologies
JMIA
$742M
| $370K | ﹤0.01% |
+72,209
| New | +$323K |
|
|
IVCBW
2017
CALL
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
| $370K | ﹤0.01% |
32,714
| – | – |
|
2018
Hagerty
HGTY
$1.23B
| $366K | ﹤0.01% |
40,035
-14,040
| -26% | -$118K |
|
2019
KT
KT
$8.98B
| $366K | ﹤0.01% |
26,105
-267,967
| -91% | -$3.7M |
|
2020
Sera Prognostics
SERA
$78.7M
| $366K | ﹤0.01% |
+40,214
| New | +$319K |
|
2021
Acumen Pharmaceuticals
ABOS
$168M
| $363K | ﹤0.01% |
+89,707
| New | +$338K |
|
2022
Pricesmart
PSMT
$5.84B
| $363K | ﹤0.01% |
4,318
+137
| +3% | +$10.9K |
|
2023
Coherus Oncology
CHRS
$224M
| $362K | ﹤0.01% |
151,563
+34,383
| +29% | +$84.6K |
|
|
VINC
2024
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $362K | ﹤0.01% |
+3,578
| New | +$226K |
|
2025
Smith-Midland
SMID
$158M
| $358K | ﹤0.01% |
+7,611
| New | +$310K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.